Watts Ryan J. sold DNLI

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001724310-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 6, 2026

Published

Jan 8, 2026

Ingested by INSIDER

Nov 5, 04:23 UTC

Last re-read

Nov 5, 04:23 UTC

Extracted facts

Filer

Watts Ryan J.

Role

Director, President and CEO

Transaction

Open-market saleAs filed: “S”

Asset

Denali Therapeutics Inc.

Ticker

DNLI

Shares

35.2K

Price per share

$16.5

Value

$580,767

Execution date (reported)

Jan 6, 2026

Owned after transaction

296.8K shares

Days from execution to publication

2

Calculation

What this establishes

Watts Ryan J. filed this Form 4 reporting a open-market sale of DNLI on Jan 6, 2026. It became public on Jan 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, President and CEO

Watts Ryan J.cik:0001724310

Issuer

Denali Therapeutics Inc.cik:0001714899

Revision history · 0

No field has changed since this record was first ingested.